Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial
Latest Information Update: 28 Feb 2025
At a glance
- Drugs Psilocybin (Primary)
- Indications Obsessive-compulsive disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms PAP-OCD
- 24 Feb 2025 Planned End Date changed from 1 Jul 2025 to 1 Oct 2025.
- 24 Feb 2025 Planned primary completion date changed from 1 Jun 2025 to 1 Aug 2025.
- 24 Feb 2025 Status changed from not yet recruiting to recruiting.